July 5, 2023 —
The first clinical trial of a three-month TB treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.
June 14, 2023 —
National data show need for more research into the diverse biological, behavioral, and social factors underlying differences in sex-based vulnerability to drug use.
